4//SEC Filing
Versant Vantage I, L.P. 4
Accession 0000899243-22-021350
CIK 0001808158other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:37 PM ET
Size
41.3 KB
Accession
0000899243-22-021350
Insider Transaction Report
Form 4
Versant Vantage I, L.P.
10% Owner
Transactions
- Sale
Common Shares
2022-06-03$12.25/sh−438,795$5,375,985→ 1,464,875 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−33,395$409,146→ 111,484 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−18,478→ 25,587 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+3,992→ 136,684 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−20,454→ 28,322 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+4,419→ 141,103 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−141,103→ 0 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−250,000$3,062,925→ 2,344,451 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−14,611$179,010→ 48,776 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−614,315→ 850,560 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+132,692→ 132,692 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−13,199$161,710→ 44,065 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−46,753→ 64,731 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+10,099→ 10,099 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−10,099→ 0 total(indirect: See Footnote)
Holdings
- 231,211
Common Shares
Versant Vantage I GP, L.P.
10% Owner
Transactions
- Sale
Common Shares
2022-06-03$12.25/sh−13,199$161,710→ 44,065 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−33,395$409,146→ 111,484 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+3,992→ 136,684 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+10,099→ 10,099 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−614,315→ 850,560 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−18,478→ 25,587 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−250,000$3,062,925→ 2,344,451 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−438,795$5,375,985→ 1,464,875 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−14,611$179,010→ 48,776 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+132,692→ 132,692 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−20,454→ 28,322 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+4,419→ 141,103 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−141,103→ 0 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−46,753→ 64,731 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−10,099→ 0 total(indirect: See Footnote)
Holdings
- 231,211
Common Shares
Versant Vantage I GP-GP, LLC
10% Owner
Transactions
- Sale
Common Shares
2022-06-03$12.25/sh−250,000$3,062,925→ 2,344,451 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−46,753→ 64,731 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+10,099→ 10,099 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−438,795$5,375,985→ 1,464,875 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−13,199$161,710→ 44,065 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−614,315→ 850,560 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−20,454→ 28,322 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−14,611$179,010→ 48,776 total(indirect: See Footnote) - Sale
Common Shares
2022-06-03$12.25/sh−33,395$409,146→ 111,484 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+132,692→ 132,692 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−18,478→ 25,587 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+3,992→ 136,684 total(indirect: See Footnote) - Other
Common Shares
2022-06-06+4,419→ 141,103 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−141,103→ 0 total(indirect: See Footnote) - Other
Common Shares
2022-06-06−10,099→ 0 total(indirect: See Footnote)
Holdings
- 231,211
Common Shares
Footnotes (19)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F10]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VAF V to its partners.
- [F11]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V.
- [F12]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VOAF I to its partners.
- [F13]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I.
- [F14]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members.
- [F15]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V (Canada) to its partners.
- [F16]Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada).
- [F17]Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F18]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners.
- [F19]Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F2]Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F3]Shares held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F4]Shares held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F5]Shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F6]Shares held by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F7]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V to its partners.
- [F8]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V.
- [F9]Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001765253
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:37 PM ET
- Size
- 41.3 KB